Provenienza dei contatti di primo grado di Kadri Vunder
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Aravis AG
 Aravis AG Investment ManagersFinance Aravis AG (Aravis) is an independent venture capital firm, founded in 2001 by Jean-Philippe Tripet and headquartered in Muttenz, Switzerland.
7
| Private Company | Investment Managers | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kadri Vunder tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Queen's University of Belfast | College/University | Doctorate Degree | |
| Luminor Capital Beijing Co. Ltd. | Director/Board Member | ||
| Chinese Business Exchange Pte Ltd. | Director/Board Member | ||
| Celltwo, Inc. Pte. Ltd. | Director/Board Member | ||
Luminor Pacific Fund 2 Ltd.
 Luminor Pacific Fund 2 Ltd. Investment ManagersFinance Luminor Pacific Fund 2 Ltd seeks investment opportunities in companies located in Asia Pacific region. The fund focuses in the companies operating in the fields of healthcare, resources, consumer, lifestyle and infrastructure sectors. It provides financing for the private equity capital requirements. | Investment Managers | Director/Board Member | |
| Luminor Harbour Fund 1 Pte Ltd. | Director/Board Member | ||
Luminor Pacific Fund 1 Ltd.
 Luminor Pacific Fund 1 Ltd. Investment ManagersFinance Luminor Pacific Fund 1 Ltd. seeks investment opportunities in the companies located in Asia Pacific region. The fund focuses in the companies operating in the fields of resources, renewable energy and recombinant technology sectors. It provides for private equity capital requirements. | Investment Managers | Director/Board Member | |
| Multiple Lodge Sdn. Bhd. | Director/Board Member | ||
| Luminor Capital Australia Pty Ltd. | Director/Board Member | ||
| Ayondo Asia Pte Ltd. | Director/Board Member | ||
| Merge Pacific Sdn. Bhd. | Director/Board Member | ||
| AYONDO LTD. | Internet Software/Services | Director/Board Member | |
King Wai Group Pte Ltd.
 King Wai Group Pte Ltd. Financial ConglomeratesFinance King Wai Group Pte Ltd. operates as a Singaporean investment company. | Financial Conglomerates | Director/Board Member | |
| ANCHOR RESOURCES LIMITED | Precious Metals | Director/Board Member | |
| NEXT GENERATION FINANCE INVEST AG | Financial Conglomerates | Director/Board Member | |
Luminor Capital Pte Ltd.
 Luminor Capital Pte Ltd. Investment ManagersFinance Luminor Capital Pte Ltd. is private equity firm founded in 2008 by Fatt Kah Foo and Chee Seng Kwan. The firm is headquartered in Singapore. | Investment Managers | Founder | |
| Maida Vale Associates Pte. Ltd. | Chief Executive Officer | ||
| VARISCAN MINES LIMITED | Other Metals/Minerals | Chairman | |
| PEC LTD. | Engineering & Construction | Director/Board Member | |
| Maida Vale Consulting Group Pte Ltd. | Director/Board Member | ||
| Myanmar Carlsberg Co. Ltd. | Director/Board Member | ||
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Vandria SA
 Vandria SA Pharmaceuticals: MajorHealth Technology Vandria SA is a Swiss-based company that specializes in mitochondrial therapeutics. The company is based in Lausanne, Switzerland. The company is developing mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318, is a brain-penetrant, patent-protected, mitophagy inducer that has shown to improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative diseases such as Alzheimer's and Parkinson's disease. Vandria is also developing mitophagy-inducing small molecules to address muscle, lung, and liver diseases, as well as a separate program that targets ferroptosis. The company was founded by Patrick Aebischer, Chris Rinsch, and Johan Auwerx in 2021 and has raised $20.60m in venture finance. Klaus Dugi has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
IP Group Plc /Venture Capital/
 IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group Plc /Venture Capital/ (IP Group) is a venture capital subsidiary of IP Group Plc founded in 2001. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
NanoDimension Management Ltd.
 NanoDimension Management Ltd. Investment ManagersFinance NanoDimension Management (NanoDimension) Ltd is a venture capital firm founded in 2002 by Aymeric Sallin. The firm is headquartered in George Town. | Investment Managers | Private Equity Investor | |
TopiVert Ltd.
 TopiVert Ltd. BiotechnologyHealth Technology TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Touchstone Innovations Investment Management Ltd.
 Touchstone Innovations Investment Management Ltd. Investment ManagersFinance Touchstone Innovations Investment Management Ltd. is a Venture Capital firm, a subsidiary of Touchstone Innovations Ltd. founded in 1986. Touchstone Innovations Investment Management Ltd. is headquartered in London. | Investment Managers | Director/Board Member | |
| Escuela de Organización Industrial | College/University | Masters Business Admin | |
| University of Barcelona | College/University | Doctorate Degree | |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Analyst | |
| Quattro Vascular Pte Ltd. | Director/Board Member | ||
| Singapore Institute of Directors | Corporate Officer/Principal | ||
| Sg Securities Asia Ltd. | Corporate Officer/Principal | ||
Amira Properties Sdn. Bhd.
 Amira Properties Sdn. Bhd. Financial ConglomeratesFinance Part of Luminor Capital Pte Ltd., Amira Properties Sdn. Bhd. provides investment services. | Financial Conglomerates | Director/Board Member | |
Accentvest Sdn. Bhd.
 Accentvest Sdn. Bhd. Financial ConglomeratesFinance Accentvest Sdn. Bhd. provides investment services. | Financial Conglomerates | Director/Board Member | |
Biosingapore
 Biosingapore Miscellaneous Commercial ServicesCommercial Services Biosingapore operates as an association of life science businesses. The private company is based in Singapore, Singapore. | Miscellaneous Commercial Services | Treasurer | |
| VCPLUS LIMITED | Precious Metals | Director/Board Member | |
| Sano V Pte. Ltd. | Director/Board Member | ||
Singapore Medtech Accelerator Pte Ltd.
 Singapore Medtech Accelerator Pte Ltd. Medical SpecialtiesHealth Technology Singapore Medtech Accelerator Pte Ltd. manufactures medical devices. The private company is based in Singapore, Singapore. The Singaporean company was founded by Eitan Konstantino. | Medical Specialties | Director/Board Member | |
| QT VASC | Medical Specialties | Director/Board Member | |
| Nouscom Srl | Miscellaneous Commercial Services | Director/Board Member | |
Biotie Therapies AG
 Biotie Therapies AG Pharmaceuticals: MajorHealth Technology Part of Acorda Therapeutics, Inc., Biotie Therapies AG is a holding company that focuses on developing drugs for the treatment of psychiatry and neurology diseases. The company is based in Zurich, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| MEDIGENE AG | Biotechnology | Chief Operating Officer |
Statistiche
Distribuzione geografica
| Singapore | 23 |
| Regno Unito | 7 |
| Svizzera | 6 |
| Malesia | 5 |
| Australia | 4 |
Settori
| Finance | 13 |
| Health Technology | 12 |
| Consumer Services | 4 |
| Non-Energy Minerals | 4 |
| Commercial Services | 4 |
Posizioni
| Director/Board Member | 62 |
| Corporate Officer/Principal | 16 |
| Private Equity Investor | 13 |
| Chief Executive Officer | 7 |
| Doctorate Degree | 7 |
Contatti più connessi
| Insiders | |
|---|---|
| Fatt Kah Foo | 34 |
| Guido Magni | 23 |
| Daniel Bach | 13 |
| Jacques R. Essinger | 12 |
| Johanna Holldack | 11 |
| Rolf M. Zinkernagel | 10 |
| Yvonne Wanders | 1 |
- Borsa valori
- Insiders
- Kadri Vunder
- Connessioni Società
